FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Ahmed, Maqbool ^a   Uddin, Shahab ^a   Hussain, Azhar R ^a   Alyan, Aisha ^a   Jehan, Zeenath ^a   Al Dayel, Fouad ^a   Al Nuaim, Abdulrehman ^a   Al Sobhi, Saif ^a   Amin, Tarek ^a   Bavi, Prashant ^a   Al Kuraya, Khawla S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GELATINASE A; GELATINASE B; PROTEIN BCL XL; SMALL INTERFERING RNA; THIOSTREPTON; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 84855510082     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1506     Document Type: Article

References (41)

1. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP 1997 Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553-3562 (Pubitemid 27509336)
2. Hay ID 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576 (Pubitemid 20282656)
3. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH 2010 Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 36:151-156
4. Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH 1999 Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 19:8570-8580 (Pubitemid 30414050)
5. Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, Lyubimov A, Costa RH 2006 Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 66:1712-1720 (Pubitemid 43259956)
6. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV 2006 The forkhead boxm1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 66:2153-2161
7. Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, Sawaya R, Huang S 2006 FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66:3593-3602
8. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN, Ngan HY 2008 Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 215:245-252 (Pubitemid 351956705)
9. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D, Xie K 2009 Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 69: 3501-3509
10. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z 2010 Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 70:2224-2234
11. Sarkar FH, Li Y, Wang Z, Kong D 2009 Cellular signaling perturbation by natural products. Cell Signal 21:1541-1547
12. Kalinichenko VV, Gusarova GA, Tan Y, Wang IC, Major ML, Wang X, Yoder HM, Costa RH, Costal RH 2003 Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Biol Chem 278:37888-37894 (Pubitemid 37175318)
13. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R 2002 The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 187:39-45 (Pubitemid 34436931)
14. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS 2001 Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7:3113-3119 (Pubitemid 32963832)
15. Wang X, Bhattacharyya D, Dennewitz MB, Kalinichenko VV, Zhou Y, Lepe R, Costa RH 2003 Rapid hepatocyte nuclear translocation of the forkhead box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes. Gene Expr 11:149-162 (Pubitemid 37516648)
16. Wang X, Krupczak-Hollis K, Tan Y, Dennewitz MB, Adami GR, Costa RH 2002 Increased hepatic forkhead box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem 277:44310-44316 (Pubitemid 36157865)
17. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH 2005 Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25:10875-10894 (Pubitemid 41747132)
18. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH 2007 Down-regulation of Forkhead BoxM1transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67:8293-8300 (Pubitemid 47395167)
19. Bavi P, Jehan Z, Atizado V, Al-Dossari H, Al-Dayel F, Tulbah A, Amr SS, Sheikh SS, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K 2006 Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis. Cancer Epidemiol Biomarkers Prev 15:1708-1718 (Pubitemid 44497108)
20. Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F, Bavi P, Hussain AR, Al-Kuraya KS 2008 Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. J Clin Endocrinol Metab 93:4088-4097
21. Uddin S, Ahmed M, Hussain A, Abubaker J, Al-Sanea N, Abdul-Jabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Jehan Z, Bavi P, Siraj AK, Al-Kuraya KS 2011 Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol 178:537-547
22. Camp RL, Dolled-Filhart M, Rimm DL 2004 X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cutpoint optimization. Clin Cancer Res 10:7252-7259 (Pubitemid 39487712)
23. Uddin S, Bavi P, Siraj AK, Ahmed M, Al-Rasheed M, Hussain AR, Ahmed M, Amin T, Alzahrani A, Al-Dayel F, Abubaker J, Bu R, Al-Kuraya KS 2010 Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer 17:191-202
24. Tanaka J, Ogura T, Sato H, Hatano M 1987 Establishment and biological characterization of an in vitro human cytomegalovirus latency model. Virology 161:62-72 (Pubitemid 17161554)
25. Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB, Myers JN 2005 The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer 92:1899-1905 (Pubitemid 40826139)
26. Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW 2008 Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther 7:2022-2032
27. Uddin S, Hussain A, Ahmed M, Belgaumi A, Al-Dayel F, Ajarim D, Bavi P, Al-Kuraya KS 2008 S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol 216:483-494
28. Hussain AR, Al-Jomah NA, Siraj AK, Manogaran P, Al-Hussein K, Abubaker J, Platanias LC, Al-Kuraya KS, Uddin S 2007 Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res 67:3888-3897 (Pubitemid 46762177)
29. Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, Al Kuraya K, Uddin S 2006 Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11:245-254 (Pubitemid 43291024)
30. Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, Sultana M, Abubaker J, Platanias LC, Al-Kuraya KS, Uddin S 2008 Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 7:3318-3329
31. Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS 2008 Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res 68:3379-3388
32. Sullivan M, Li J, Kumar S, Rogers MJ, McCutchan TF 2000 Effects of interruption of apicoplast function on malaria infection, development, and transmission. Mol Biochem Parasitol 109:17-23 (Pubitemid 30621372)
33. Bhat UG, Halasi M, Gartel AL 2009 FoxM1 is a general target for proteasome inhibitors. PLoS One 4:e6593
34. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhuri P, Costa RH 2004 Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 18:830-850 (Pubitemid 38480894)
35. Billen LP, Shamas-Din A, Andrews DW 2008 Bid: a Bax-like BH3 protein. Oncogene 27(Suppl 1):S93-S104
36. Myatt SS, Lam EW 2007 The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7:847-859 (Pubitemid 350006253)
37. Nakamura S, Hirano I, Okinaka K, Takemura T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S, Ohnishi K 2010 The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis 31:2012-2021
38. Sumimoto H, Yamagata S, Shimizu A, Miyoshi H, Mizuguchi H, Hayakawa T, Miyagishi M, Taira K, Kawakami Y 2005 Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference. Gene Ther 12:95-100 (Pubitemid 40090049)
39. Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R 2007 p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther 6:2696-2707 (Pubitemid 350058150)
40. Hong L, Zhao Y, Han Y, Guo W, Jin H, Qiao T, Che Z, Fan D 2007 Mechanisms of growth arrest by zinc ribbon domain-containing 1 in gastric cancer cells. Carcinogenesis 28:1622-1628 (Pubitemid 47289022)
41. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH 2010 FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 122:337-346